A government vaccine specialist who was moved out of his job last month alleges that the U.S. Department of Health and Human Services resisted his warnings about the dangers of the coronavirus and removed him from his position for raising alarms about an antimalarial drug President Trump had touted as a potential treatment. Rick Bright, who had led an HHS division on biomedical research, portrayed agency leadership as dismissing his concerns about the novel coronavirus in a complaint filed Tuesday with the Office of Special...

Source: Wall Street Journal May 05, 2020 22:24 UTC